✦ LIBER ✦

Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial

✍ Scribed by Yvonne M van Kasteren; Didi D.M Braat; Douwe J Hemrika; Cornelis B Lambalk; Lyset T.M Rekers-Mombarg; B.Mary E von Blomberg; Joop Schoemaker

Book ID: 119423083
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 74 KB
Volume: 71
Category: Article
ISSN: 1556-5653
DOI: 10.1016/s0015-0282(98)00411-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of pretreatment with estrogens o

Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial

✍ Massimo Tartagni; Ettore Cicinelli; Giovanni De Pergola; Maria Antonietta De Sal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Does metformin affect the ovarian respon

Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial

✍ Stefano Palomba; Angela Falbo; Annalisa Di Cello; Fulvio Cappiello; Achille Toli 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Captopril improves hemodynamic response

Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: A double-blind, placebo-controlled, randomized trial

✍ C. Borgi; F. V. Costa; E. Ambrosioni; C. Magelli; B. Magnani 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Prevention of Ovarian Hyperstimulation S

Prevention of Ovarian Hyperstimulation Syndrome (OHSS) With the Use of Gonadotropin Releasing Hormone (GnRH) Agonist to Trigger Final Oocyte Maturation After Cotreatment With GnRH Antagonist in Patients With Polycystic Ovarian Syndrome (PCOS) or Previous High Response Undergoing IVF Treatment—A Prospective Randomized Clinical Trial

✍ L. Engmann; A. Diluigi; D. Schmidt; J. Nulsen; D. Maier; C. Benadiva 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 91 KB

5002 ORAL Results from a Phase II random

5002 ORAL Results from a Phase II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of pertuzumab to gemcitabine in patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer

✍ Makhija, S.; Glenn, D.; Ueland, F.; Dizon, D.; Paton, V.; Lin, C.Y.; Amler, L.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB